RecruitingNot ApplicableNCT06920979

Stop Sepsis Through Home Monitoring Cooperative


Sponsor

University Hospital, Antwerp

Enrollment

120 participants

Start Date

Feb 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

In this study, patients presenting with acute infections at risk of developing sepsis will be followed in their home setting using wearables that provide (semi-)continue monitoring of vital signs as well as through follow up using a designated smartphone application. This is an innovative pilot study that will examine the potential of transmural care through telemonitoring for the first time in patients at risk for developing sepsis. By allowing for active follow-up of vital parameters in a transmural setting, this project aims to reduce the number of hospitalizations as compared to current practice. Furthermore, we aim to the number of patients referred to the emergency department after a visit at their primary care physician. Thereby, we aim to reduce the healthcare burden, yet providing the ability for rapid intervention in case of detarioration of patients, thereby reducing morbidity and mortality as well as associated costs.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying (semi)continue monitoring of patients at risk for sepsis at home for people with home monitoring follow-up, infection, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHER(semi)continue monitoring of patients at risk for sepsis at home

(semi)continue monitoring of patients at risk for sepsis at home


Locations(1)

Antwerp University Hospital (UZA)

Edegem, Antwerpen, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06920979


Related Trials